# China NMPA Drug Inspection - Hunan Jinyitang Pharmaceutical Co., Ltd. - Bupleurum (Northern Bupleurum)

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/hunan-jinyitang-pharmaceutical-co-ltd/9421644f-20cd-4a90-8a9f-aa014ce5abaf
Source feed: China

> China NMPA drug inspection for Hunan Jinyitang Pharmaceutical Co., Ltd. published March 25, 2020. Drug: Bupleurum (Northern Bupleurum). 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 1, 2020)
- Company Name: Hunan Jinyitang Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-25
- Drug Name: Bupleurum (Northern Bupleurum)
- Inspection Finding: [Characteristics]
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/hunan-jinyitang-pharmaceutical-co-ltd/73d3d3b8-e88b-4989-819a-c65073e2cb4a